-+ 0.00%
-+ 0.00%
-+ 0.00%

CRESCENT BIOPHARMA - MULTIPLE SAC-TMT PLUS CR-001 PHASE 2 STUDIES ONGOING IN OVER 700 PATIENTS; DATA MID-2027

路透·10/15/2026 20:16:12

請登錄查看新聞詳情